Lanean...
Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
There is considerable interest and enthusiasm within the clinical gynecologic oncology community regarding the potential for poly (ADP-ribose) polymerase inhibitors to play a critically relevant role in the management of epithelial ovarian cancer and particularly (although not exclusively) in the se...
Gorde:
| Argitaratua izan da: | Womens Health (Lond) |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784554/ https://ncbi.nlm.nih.gov/pubmed/29313444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1745505717750694 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|